12/3/2021BeiGene and EUSA Announce CN Approval of SYLVANT (Siltuximab for Inje...

12/3/2021Recent Executive Moves

12/2/2021NMPA Solicits Comments on the Draft Guidelines for Pharmacovigilance I...

12/2/2021WuXi STA and Coherent Biopharma Forms Strategic Partnership 

12/2/2021NHSA and MOHRSS Officially Issue the 2021 NRDL, Adding 74 and Removing...

12/1/2021Innovent and Ascentage Granted NMPA Approval for China's First 3rd Ge...

12/1/2021Genetron and AstraZeneca China Enter Co-Development Agreement for MR...

12/1/2021Novo Nordisk, Sanofi and Eli Lilly Cut Insulin Prices and Lose Share i...

11/30/2021NMPA Issues the Dossier Requirements for Import and Export Permit of N...

11/30/2021NMPA Announces Package Insert Revision of Glycerol Fructose and Sodium...

11/30/2021JPO Releases Final Tender Outcome of the 6th VBP

11/30/2021Jemincare Licenses Kras Inhibitor JMKX1899 to HUYABIO 

11/30/2021Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...

11/30/2021Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...

11/30/2021NH's DB6: Pandemic Continues to Dictate CHC Trends with China Recoveri...

11/29/2021NHSA Issues Three-Year Action Plan on DRD/DIP Payment System Reform (S...

11/26/2021Luye Subsidiary Boan Bio Signs MOU with Merck to Build Next-Gen Digit...

11/26/2021Simcere Announces CN Conditional Approval of Enweida (Envafolimab) C...

11/26/2021Recent Executive Movements

11/24/2021HUTCHMED and AZ Initiate SACHI P3 Trial of ORPATHYS and TAGRISSO Com...

11/24/2021NMPA Announces Package Insert Revision of Disodium Clodronate Formulat...

11/24/2021BeiGene Completes Acquisition of Former BMS Campus in NJ

11/24/2021API Manufacturers Targeted by China's New Anti-monopoly Bureau: Pharma...

11/23/2021PharmaDJ's China Licensing Deals Tracker: October 2021

11/23/2021NHC Issues Notice on Promotion of Sanming City's Healthcare Reform Exp...

11/23/2021Ji Xing Granted Chinese IND Approval for Phase 1 & 3 Trials of Etripam...

11/23/2021Lonza and Bluejay Therapeutics Ink Manufacturing Deal

11/23/2021Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from...

11/22/2021CStone and Hengrui Enter Licensing Pact on Anti-CTLA-4 mAb CS1002 in ...

11/22/2021Independent Directors of Kangmei Pharma Fined Heavily, Triggering A Qu...

Page:80/360 Total number of articles:10791: [First][<<] [78] [79] [80] [81] [82] [>>] [End]